Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial (Q35359181)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

0 references

(RS)-ketoprofen

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

A E Muñoz

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

D Levi

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

A Podestá

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

J M Gorín

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

J González

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

M A Bartellini

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

M S Munne

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

A Cabanne

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

D Flichman

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

R Terg

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

427-431

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Changing the natural history of HIV disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Histological grading and staging of chronic hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Biosynthesis of prostaglandins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Signal transduction by interferon-alpha through arachidonic acid metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Elsewhere reviews. Interferon signalling through arachidonic acid-dependent pathways: A clue to adjuvant therapy for chronic viral hepatitis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

12 July 2018

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

26 September 2018

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

26 September 2018

Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

26 September 2018

Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727838

26 September 2018

Inhibition of murine natural killer cell activity by prostaglandins

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Drug-induced hepatotoxicity. Eleventh update of the bibliographic database on liver injuries and responsible drugs]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy for interferon-resistant patients: do cyclooxygenase inhibitors have any role? A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of Ketoprofen and Interferon Combination Therapy to Improve Interferon‐Resistant Chronic Hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/10673309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.46.3.427

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35359181&oldid=1614186643"